Pharmaceutical Technology Quality and Regulatory Sourcebook
Read the article:
Facilitating Biopharma Continuous Manufacturing
Read the ebook:
Pharmaceutical Technology Quality and Regulatory Sourcebook Ebook
CONTINUE TO SITE
OR WAIT null SECS
Advertisement
- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Contacts
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2024 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Facilitating Biopharma Continuous Manufacturing
Published on:
Jennifer Markarian
Pharmaceutical Technology, Pharmaceutical Technology, Regulatory Sourcebook, March 2022, Volume 2022 eBook, Issue 1
Pages: 52-54
USP is advancing understanding and developing guidance and standards to assist industry in implementing continuous manufacturing.
Manufacturers, regulators, and other industry organizations are aiming to advance biopharmaceutical continuous manufacturing and to connect upstream and downstream into fully continuous processes. The United States Pharmacopeial Convention (USP), a nonprofit organization known for developing standards for quality, is actively involved in facilitating implementation of continuous manufacturing in the bio/pharmaceutical industry. Pharmaceutical Technology spoke with John Kokai-Kun, director, External Scientific Collaboration at USP about these efforts.
Advertisement
Read “Facilitating Biopharma Continuous Manufacturing” in Pharmaceutical Technology’s Quality and Regulatory Sourcebook Ebook.
Article details:
Pharmaceutical Technology
eBook: Quality and Regulatory Sourcebook
March 2022
Pages: 52-54
Citation
When referring to this article, please cite it as J. Markarian, “Facilitating Biopharma Continuous Manufacturing,” Pharmaceutical Technology’s Quality and Regulatory Sourcebook eBook (March 2022).
